GMED Class A Globus Medical, Inc. Class A Common Stock
NYSE · Health Care · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 6, 2026
$75.60
· of 52w range
· above low
· to high
$56.5052w low
$101.4052w high
P/E (TTM)
19.4
EPS (TTM)
$3.89
Revenue (TTM)
$3.14B
your badges
52W Range
$56–$101
Analyst Rating
BUY
Price Target
$101
P/E
19.4
ROE
11.8%
Net Profit Margin
17.0%
Your badge strip is empty — pin a metric anywhere on this page.
GMED Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$75.60
P/E (TTM)
19.4
EPS (TTM)
$3.89
Revenue (TTM)
$3.14B
ROE (TTM)
11.8%
52W Range
$57–$101
GMED Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
About Globus Medical, Inc. Class A Common Stock Company overview from Wikipedia
Globus Medical, Inc. is a publicly traded orthopedic medical device company headquartered in Audubon, Pennsylvania, United States. Globus is focused on the design, development, and commercialization of products that enable surgeons to promote healing in patients with musculoskeletal disorders.
Products
Globus develops, manufactures, and markets orthopedic implants including spine, trauma, and artificial joints.
Globus Medical makes the ExcelsiusGPS surgical robotic system for spine surgery. The robot is used for transpedicular drilling and screw placement. In November 2024, the company launched its ExcesiusHub, an advanced surgical navigation system for robotic surgical procedures.
The ADIRA XLIF Plate System aids in enhancing lateral spine surgery procedures.
Acquisitions
In January 2014, Globus Medical acquired Excelsius Surgical. The Excelsius system is designed to integrate intra-operative digital imaging with a robotic surgery device to hold patients in place during surgeries "with sub-millimeter accuracy". In October of that year, the company acquired allograft tissue processor Transplant Technologies of Texas, Ltd. (TTOT). TTOT provides human tissue products, including bone allografts, biomaterials, and soft tissue products for spine, orthopedics, sports medicine, dental, and wound care markets.
In February 2015, Globus Medical acquired Branch Medical Group, a third-party manufacturer of high-precision medical devices.
In July 2016, Globus Medical acquired Alphatec Holdings, an international operations and distribution channel, for $80 million. As part of the transaction, Globus has agreed to provide Alphatec a five-year senior secured credit facility of up to $30 million.
In September 2018, Globus Medical acquired Nemaris, developers of Surgimap, a pre-operative planning software for spinal surgeons.
In August 2019, Globus Medical acquired privately owned StelKast, manufacturer of implants and instruments for hip and knee replacement.
In February 2023, Globus Medical acquired NuVasive in an all-stock deal valued at $3.1 billion.
Controversies
In August 2007 Globus Medical settled a lawsuit initially filed by Synthes in 2004 over alleged stolen trade secrets. Former Synthes employees, who then worked for Globus, were accused of stealing 2300 electronic files containing blueprints for Synthes' products, safety-testing plans, and verbatim 510(k) filing documents. Globus paid Synthes $13.5 million and did not admit any wrongdoing.
In 2011, Synthes filed a second lawsuit against Globus Medical for infringing three patents, "asking the court to force the defendant to destroy its allegedly infringing products." Orthopedic Design & Technology Magazine reports that, "There was no finding of willful infringement in this lawsuit." A $16 million monetary damage was paid by Globus Medical in 2013.
Source: Wikipedia, CC BY-SA 4.0 · View on Wikipedia ↗
sectorHealth Care
industryHealth Care
employees6,000
countryUS
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$2.94B2016-12-31 → 2025-12-31
EPS$3.922016-12-31 → 2025-12-31
Free Cash Flow$589M2016-12-31 → 2025-12-31
Net margin17.0%2016-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | GMED | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | 19.45Y avg ≈54.5 | ≈54.5 | 28.6 | Undervalued | |
| PEG Ratio | ≈0.6 | · | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | GMED | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Operating Margin (TTM) | 20.3%5Y avg ≈12.3% | ≈12.3% | 13.1% | Top tier | |
| EBITDA Margin (TTM) | 29.2%5Y avg ≈21.3% | ≈21.3% | 13.7% | Top tier | |
| Pretax Margin (TTM) | 21.0%5Y avg ≈13.7% | ≈13.7% | 11.8% | Top tier | |
| Net Profit Margin (TTM) | 17.0%5Y avg ≈11.4% | ≈11.4% | 9.0% | Top tier | |
| ROA (TTM) | 10.2%5Y avg ≈6.0% | ≈6.0% | 4.6% | Top tier | |
| ROE (TTM) | 11.8%5Y avg ≈6.6% | ≈6.6% | 8.9% | Top tier | |
| ROIC | 9.3%5Y avg ≈5.8% | ≈5.8% | 7.1% | Top tier |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | GMED | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 4.65Y avg ≈4.5 | ≈4.5 | 2.4 | Strong liquidity | |
| Quick Ratio (MRQ) | 2.75Y avg ≈1.9 | ≈1.9 | 1.0 | Strong liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | GMED | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | 16.7%5Y avg ≈31.8% | ≈31.8% | · | · | |
| Revenue CAGR 3Y | 42.2%5Y avg ≈35.3% | ≈35.3% | · | · | |
| Revenue CAGR 5Y | 30.1% | · | · | · | |
| EPS YoY | 422.7%5Y avg ≈84.3% | ≈84.3% | · | · | |
| Net Income YoY | 422.3%5Y avg ≈88.8% | ≈88.8% | · | · | |
| EPS CAGR 3Y | 28.4%5Y avg ≈3.6% | ≈3.6% | · | · | |
| EPS CAGR 5Y | 31.2% | · | · | · | |
| Net Income CAGR 3Y | 41.4%5Y avg ≈12.0% | ≈12.0% | · | · | |
| Net Income CAGR 5Y | 39.4% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | GMED | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.65Y avg ≈0.5 | ≈0.5 | 0.5 | In line | |
| Inventory Turnover | 1.45Y avg ≈1.2 | ≈1.2 | 1.8 | Weak | |
| Receivables Turnover | 4.85Y avg ≈5.0 | ≈5.0 | 6.2 | Weak | |
| Revenue / Employee | ≈$489.8K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
16.2%
Next Report
Nov 04, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 5, 2026 | $1.34 | $1.12 | 19.5% |
| March 31, 2026 | May 12, 2026 | $1.12 | $0.94 | 19.4% |
| Dec. 31, 2025 | $1.28 | $1.17 | 9.2% | |
| Sept. 30, 2025 | $1.18 | $0.80 | 47.8% | |
| June 30, 2025 | $0.86 | $0.77 | 11.6% | |
| March 31, 2025 | $0.68 | $0.76 | -10.4% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.94B | $2.52B | $1.57B | $1.02B | $958M | $789M | $785M | $713M | $636M | $564M | $545M | $474M | |
| Cost of Revenue | $958M | $1.04B | $548M | $264M | $239M | $217M | $180M | $159M | $150M | $135M | $132M | $111M | |
| Gross Profit | · | · | $1.02B | $759M | $719M | $572M | $605M | $554M | $486M | $429M | $412M | $364M | |
| R&D Expense | $147M | $164M | $124M | $73M | $97M | $85M | $60M | $55M | $44M | $45M | $36M | $31M | |
| SG&A Expense | $1.18B | $981M | $644M | $432M | $408M | $355M | $355M | $312M | $268M | $222M | $210M | $189M | |
| Operating Expenses | · | · | $887M | $531M | $547M | $460M | $433M | $384M | $324M | $275M | $240M | $225M | |
| Operating Income | $480M | $166M | $133M | $228M | $172M | $111M | $172M | $169M | $162M | $154M | $172M | $138M | |
| Other Non-op | $3M | $2M | $-2M | $2M | $8M | $14M | $18M | $19M | $8M | $3M | $583.0K | $280.0K | |
| Pretax Income | $605M | $121M | $165M | $243M | $180M | $126M | $190M | $189M | $170M | $157M | $173M | $139M | |
| Income Tax | $67M | $18M | $43M | $53M | $31M | $24M | $35M | $32M | $63M | $53M | $60M | $46M | |
| Net Income | $538M | $103M | $123M | $190M | $149M | $102M | $155M | $156M | $107M | $104M | $113M | $92M | |
| EPS (Basic) | $3.98 | $0.76 | $1.09 | $1.89 | $1.48 | $1.04 | $1.57 | $1.60 | $1.12 | $1.09 | $1.19 | $0.98 | |
| EPS (Diluted) | $3.92 | $0.75 | $1.07 | $1.85 | $1.44 | $1.01 | $1.52 | $1.54 | $1.10 | $1.08 | $1.17 | $0.97 | |
| Shares (Basic) | 135,215,000 | 135,726,000 | 113,087,000 | 100,469,000 | 100,734,000 | 98,580,000 | 99,150,000 | 97,884,000 | 96,243,000 | 95,647,000 | 95,046,000 | 94,227,000 | |
| Shares (Diluted) | 137,056,000 | 137,863,000 | 114,630,000 | 102,643,000 | 103,623,000 | 100,971,000 | 101,998,000 | 101,316,000 | 97,887,000 | 96,432,000 | 96,073,000 | 95,457,000 | |
| EBITDA | $757M | $420M | $278M | · | $242M | $174M | $225M | $211M | $204M | $193M | $196M | $160M |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $526M | $784M | · | · | · | · | $195M | $140M | $119M | $67M | $58M | $82M | |
| Short-term Investments | $31M | $106M | $50M | $296M | $250M | $187M | · | $200M | $255M | $223M | $221M | $146M | |
| Receivables | $679M | $558M | $503M | $213M | $164M | $142M | $154M | $137M | $117M | $92M | $78M | $75M | |
| Inventory | $759M | $659M | $848M | $299M | $237M | $229M | $196M | $131M | $108M | $113M | $105M | $91M | |
| Prepaid Expense | $65M | $50M | $45M | $21M | $18M | $18M | $17M | $15M | $11M | $15M | $7M | $6M | |
| Current Assets | $2.13B | $2.18B | $1.92B | $983M | $865M | $822M | $687M | $631M | $620M | $514M | $545M | $470M | |
| PP&E (Net) | $564M | $562M | $587M | $244M | $221M | $217M | $200M | $172M | $143M | $124M | $115M | $69M | |
| PP&E (Gross) | $1.27B | $1.11B | $1.01B | $587M | $527M | $493M | $444M | $389M | $335M | $291M | $254M | $188M | |
| Accum. Depreciation | $705M | $546M | $426M | $343M | $306M | $276M | $244M | $217M | $192M | $167M | $139M | $119M | |
| Goodwill | $1.44B | $1.43B | $1.43B | $197M | $180M | $157M | $129M | $124M | $124M | $106M | $92M | $53M | |
| Intangibles | $745M | $795M | $925M | $64M | $69M | $87M | $79M | $87M | $79M | $62M | $33M | $35M | |
| Other Non-current Assets | $79M | $75M | $79M | $37M | $36M | $32M | $22M | $10M | $8M | $928.0K | $590.0K | $975.0K | |
| Total Assets | $5.30B | $5.25B | $5.09B | $2.08B | $1.96B | $1.68B | $1.53B | $1.30B | $1.08B | $928M | $834M | $704M | |
| Accounts Payable | $99M | $75M | $57M | $36M | $22M | $18M | $25M | $26M | $25M | $17M | $16M | $16M | |
| Accrued Liabilities | $334M | $261M | $240M | $92M | $91M | $78M | $63M | $60M | $53M | $46M | $54M | $61M | |
| Current Liabilities | $498M | $856M | $392M | $159M | $140M | $121M | $111M | $96M | $93M | $80M | $83M | $89M | |
| Capital Leases | $104M | $84M | $91M | $3M | $3M | $3M | $1M | · | · | · | · | · | |
| Deferred Tax | · | $24M | $84M | $2M | $4M | $6M | $6M | $8M | $11M | $8M | $13M | $5M | |
| Other Non-current Liabilities | $21M | $22M | $25M | $10M | $13M | $15M | $9M | $8M | $2M | $2M | $2M | $3M | |
| Total Liabilities | $730M | $1.07B | $1.09B | $230M | $216M | $173M | $130M | $115M | $111M | $96M | $119M | $118M | |
| Paid-in Capital | $3.17B | $3.03B | $2.87B | $631M | $554M | $457M | $357M | $300M | $238M | $212M | $193M | $175M | |
| Retained Earnings | $1.39B | $1.15B | $1.14B | $1.24B | $1.19B | $1.05B | $1.05B | $893M | $736M | $629M | $525M | $412M | |
| AOCI | $15M | $-7M | $-10M | $-25M | $-7M | $4M | $-3M | $-7M | $-7M | $-9M | $-2M | $-2M | |
| Stockholders' Equity | $4.57B | $4.18B | $4.00B | $1.85B | $1.74B | $1.51B | $1.40B | $1.19B | $968M | $832M | $715M | $585M | |
| Liabilities + Equity | $5.30B | $5.25B | $5.09B | $2.08B | $1.96B | $1.68B | $1.53B | $1.30B | $1.08B | $928M | $834M | $704M | |
| Shares Outstanding | · | · | · | · | · | · | 99,825,080 | 98,573,354 | 96,657,881 | 95,929,916 | 95,319,722 | 94,705,743 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $277M | $253M | $146M | $68M | $70M | $63M | $53M | $42M | $42M | $39M | $24M | $22M | |
| Stock-based Comp | $50M | $54M | $53M | $33M | $31M | $27M | $26M | $22M | $15M | $11M | $10M | $7M | |
| Deferred Tax | · | $-134M | $-58M | $-22M | $-18M | $-4M | $4M | $971.0K | $8M | $-4M | $6M | $-4M | |
| Amort. of Intangibles | $118M | $119M | $51M | $18M | $19M | $17M | $14M | $10M | $8M | $3M | $2M | $712.0K | |
| Restructuring | · | $30M | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | $-111M | $243M | $-19M | · | $44M | $11M | $-66M | $-39M | $-13M | $22M | $-31M | $-38M | |
| Operating Cash Flow | $753M | $521M | $243M | $178M | $276M | $199M | $172M | $182M | $159M | $148M | $124M | $79M | |
| CapEx | $165M | $115M | $78M | $74M | $57M | $64M | $71M | $60M | $51M | $41M | $51M | $25M | |
| Investing Cash Flow | $-355M | $-176M | $303M | $-110M | $-376M | $-117M | $-140M | $-193M | $-111M | $-163M | $-153M | $-100M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | · | $10M | |
| Stock Repurchased | $300M | $86M | $226M | $144M | · | $105M | · | · | · | · | · | · | |
| Net Stock Activity | $-300M | $-86M | $-226M | · | · | $-105M | · | · | · | · | · | $10M | |
| Financing Cash Flow | $-679M | $-28M | $-232M | $-110M | $54M | $-39M | $24M | $33M | $2M | $470.0K | $4M | $13M | |
| Net Change in Cash | $-258M | $317M | $317M | $-43M | $-46M | $44M | $56M | $21M | $51M | $-16M | $-25M | $-8M | |
| Taxes Paid | $99M | $159M | $101M | $78M | $45M | $25M | $34M | $31M | · | · | · | · | |
| Free Cash Flow | $589M | $405M | $165M | · | $219M | $135M | $101M | $122M | $108M | $131M | $71M | $54M |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | 65.0% | · | 75.0% | 72.4% | 77.1% | 77.6% | 76.3% | 76.1% | 75.6% | 76.6% | |
| Operating Margin | 16.3% | 6.6% | 8.5% | · | 17.9% | 14.1% | 21.9% | 23.8% | 25.4% | 27.3% | 31.6% | 29.2% | |
| Net Margin | 18.3% | 4.1% | 7.8% | · | 15.6% | 13.0% | 19.8% | 21.9% | 16.9% | 18.5% | 20.7% | 19.5% | |
| Pretax Margin | 20.6% | 4.8% | 10.5% | · | 18.8% | 16.0% | 24.2% | 26.5% | 26.7% | 27.9% | 31.7% | 29.2% | |
| EBITDA Margin | 25.8% | 16.7% | 17.7% | · | 25.2% | 22.1% | 28.6% | 29.6% | 32.1% | 34.2% | 36.0% | 33.8% | |
| ROA | 10.2% | 2.0% | 3.4% | · | 8.2% | 6.4% | 11.0% | 13.2% | 10.7% | 11.8% | 14.7% | 14.6% | |
| ROE | 12.1% | 2.5% | 3.0% | · | 8.6% | 7.0% | 11.3% | 13.5% | 11.9% | 13.5% | 17.3% | 17.5% | |
| ROIC | 9.3% | 3.4% | 2.5% | · | 8.2% | 6.0% | 10.0% | 11.8% | 10.6% | 12.3% | 15.7% | 15.8% |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.3 | 2.5 | 4.9 | · | 6.2 | 6.8 | 6.2 | 6.6 | 6.7 | 6.4 | 6.6 | 5.3 | |
| Quick Ratio | 2.5 | 0.8 | 1.4 | · | 3.0 | 1.2 | 3.1 | 5.0 | 5.3 | 4.8 | 4.3 | 3.4 |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.5 | 0.4 | · | 0.5 | 0.5 | 0.6 | 0.6 | 0.6 | 0.6 | 0.7 | 0.7 | |
| Inventory Turnover | 1.4 | 1.4 | 1.0 | · | 1.0 | 1.0 | 1.1 | 1.3 | 1.4 | 1.2 | 1.4 | 1.4 | |
| Receivables Turnover | 4.8 | 4.7 | 4.4 | · | 6.3 | 5.3 | 5.4 | 5.6 | 6.1 | 6.6 | 7.1 | 6.9 |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | · | · | · | · | · | $14.05 | $12.03 | $10.01 | $8.67 | $7.50 | $6.18 | |
| Revenue / Share | $21.44 | $18.27 | $13.68 | · | $9.25 | $7.81 | $7.70 | $7.04 | $6.50 | $5.85 | $5.67 | $4.97 | |
| Cash Flow / Share | $5.50 | $3.78 | $2.12 | · | $2.67 | $1.97 | $1.69 | $1.79 | $1.63 | $1.78 | $1.27 | $0.83 | |
| Cash / Share | · | · | · | · | · | · | $1.96 | $1.42 | $1.23 | $1.38 | $0.63 | $0.87 | |
| EPS (TTM) | $3.92 | $0.75 | $1.07 | $1.85 | $1.44 | $1.01 | $1.52 | $1.54 | $1.10 | $1.08 | $1.17 | $0.97 |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 16.7% | 60.6% | 53.3% | 6.8% | 21.4% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 42.2% | 38.0% | 25.7% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 30.1% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 422.7% | -29.9% | -42.2% | 28.5% | 42.6% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 28.4% | -19.5% | 1.9% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 31.2% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | 422.3% | -16.2% | -35.4% | 27.5% | 45.9% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 41.4% | -11.6% | 6.3% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 39.4% | · | · | · | · | · | · | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2.94B | $2.52B | $1.57B | $1.02B | $958M | $789M | $785M | $713M | $636M | $564M | $545M | $474M | |
| Net Income TTM | $538M | $103M | $123M | $190M | $149M | $102M | $155M | $156M | $107M | $104M | $113M | $92M | |
| Market Cap | · | · | · | · | · | · | $5.88B | $4.27B | $3.97B | $2.38B | $2.65B | $2.25B | |
| P/E | 22.3 | 110.3 | 49.8 | 40.1 | 50.1 | 64.6 | 38.7 | 28.1 | 37.4 | 23.0 | 23.8 | 24.5 | |
| P/S | · | · | · | · | · | · | 7.5 | 6.0 | 6.2 | 4.2 | 4.9 | 4.7 | |
| P/B | · | · | · | · | · | · | 4.2 | 3.6 | 4.1 | 2.9 | 3.7 | 3.8 | |
| P / Cash Flow | · | · | · | · | · | · | 34.2 | 23.5 | 24.9 | 13.8 | 21.7 | 28.4 | |
| P / FCF | · | · | · | · | · | · | 58.1 | 35.0 | 36.7 | 18.2 | 37.2 | 41.4 | |
| Earnings Yield | 4.5% | 0.91% | 2.0% | 2.5% | 2.0% | 1.6% | 2.6% | 3.6% | 2.7% | 4.3% | 4.2% | 4.1% |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $790M | $760M | $826M | $769M | $745M | $598M | $657M | $626M | $630M | $607M | $617M | $384M | $292M | $277M | $274M | $254M | |
| Cost of Revenue | $241M | $234M | $261M | $253M | $249M | $195M | $263M | $271M | $260M | $241M | $265M | $135M | $76M | $71M | $71M | $65M | |
| Gross Profit | · | · | · | · | · | · | · | · | $370M | $365M | · | $248M | $215M | $206M | · | $189M | |
| R&D Expense | $36M | $37M | $36M | $38M | $40M | $33M | $33M | $35M | $38M | $57M | $52M | $29M | $21M | $21M | $20M | $19M | |
| SG&A Expense | $287M | $298M | $318M | $314M | $304M | $243M | $253M | $240M | $239M | $249M | $245M | $156M | $120M | $122M | $118M | $107M | |
| Operating Expenses | · | · | · | · | · | · | · | · | $320M | $357M | · | $248M | $149M | $149M | · | $129M | |
| Operating Income | $182M | $150M | $169M | $137M | $76M | $97M | $60M | $48M | $50M | $8M | $10M | $404.0K | $66M | $56M | $54M | $60M | |
| Other Non-op | $1M | $2M | $391.0K | $2M | $772.0K | $713.0K | $1M | $-570.0K | $997.0K | $710.0K | $-17M | $-475.0K | $8M | $7M | $-5M | $2M | |
| Pretax Income | $190M | $157M | $169M | $144M | $188M | $104M | $25M | $57M | $48M | $-9M | $25M | $3M | $75M | $63M | $62M | $61M | |
| Income Tax | $38M | $33M | $29M | $25M | $-15M | $28M | $-2M | $5M | $16M | $-1M | $10M | $2M | $17M | $14M | $12M | $14M | |
| Net Income | $152M | $124M | $141M | $119M | $203M | $75M | $27M | $52M | $32M | $-7M | $15M | $998.0K | $58M | $49M | $50M | $47M | |
| EPS (Basic) | $1.12 | $0.92 | $1.05 | $0.88 | $1.50 | $0.55 | $0.20 | $0.38 | $0.23 | $-0.05 | $0.02 | $0.01 | $0.57 | $0.49 | $0.50 | $0.48 | |
| EPS (Diluted) | $1.10 | $0.90 | $1.01 | $0.88 | $1.49 | $0.54 | $0.19 | $0.38 | $0.23 | $-0.05 | $0.01 | $0.01 | $0.57 | $0.48 | $0.48 | $0.47 | |
| Shares (Basic) | 135,054,000 | 135,364,000 | · | 134,502,000 | 135,205,000 | 136,757,000 | · | 135,615,000 | 135,195,000 | 135,358,000 | · | 113,537,000 | 100,373,000 | 100,279,000 | · | 99,652,000 | |
| Shares (Diluted) | 137,384,000 | 138,191,000 | · | 135,394,000 | 136,499,000 | 139,774,000 | · | 138,062,000 | 136,979,000 | 135,358,000 | · | 115,245,000 | 101,782,000 | 102,196,000 | · | 101,417,000 | |
| EBITDA | $182M | $220M | · | $137M | $76M | $163M | · | $48M | $50M | $63M | · | $404.0K | $66M | $75M | · | $60M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $508M | $561M | $526M | · | · | · | $784M | · | · | · | · | · | · | · | · | · | |
| Short-term Investments | $87M | $69M | $31M | $19M | · | · | $106M | $72M | $83M | $80M | · | $189M | $306M | $287M | · | $271M | |
| Receivables | $692M | $686M | $679M | $619M | $612M | $535M | $558M | $588M | $612M | $534M | · | $494M | $240M | $223M | · | $206M | |
| Inventory | $811M | $773M | $759M | $772M | $772M | $664M | $659M | $718M | $770M | $816M | · | $905M | $336M | $321M | · | $282M | |
| Prepaid Expense | $70M | $60M | $65M | $74M | $68M | $47M | $50M | $51M | $46M | $43M | · | $48M | $20M | $19M | · | $24M | |
| Current Assets | $2.22B | $2.20B | $2.13B | $1.92B | $1.73B | $1.71B | $2.18B | $2.06B | $1.92B | $1.83B | · | $1.92B | $1.21B | $1.07B | · | $920M | |
| PP&E (Net) | $534M | $557M | $564M | $578M | $588M | $556M | $562M | $568M | $572M | $579M | · | $607M | $248M | $245M | · | $236M | |
| PP&E (Gross) | $1.30B | $1.30B | $1.27B | $1.22B | $1.19B | $1.13B | $1.11B | $1.07B | $1.05B | $1.03B | · | $995M | $612M | $599M | · | $569M | |
| Accum. Depreciation | $770M | $748M | $705M | $647M | $602M | $572M | $546M | $506M | $480M | $447M | · | $388M | $364M | $354M | · | $333M | |
| Goodwill | $1.44B | $1.44B | $1.44B | $1.43B | $1.43B | $1.43B | $1.43B | $1.43B | $1.45B | $1.45B | $1.43B | $1.12B | $199M | $199M | $197M | $182M | |
| Intangibles | $693M | $721M | $745M | $774M | $796M | $772M | $795M | $843M | $867M | $888M | · | $1.26B | $55M | $59M | · | $54M | |
| Other Non-current Assets | $79M | $79M | $79M | $77M | $75M | $75M | $75M | $77M | $78M | $78M | · | $69M | $47M | $45M | · | $36M | |
| Total Assets | $5.49B | $5.44B | $5.30B | $5.10B | $4.96B | $4.71B | $5.25B | $5.09B | $4.99B | $4.94B | · | $5.36B | $2.21B | $2.15B | · | $1.98B | |
| Accounts Payable | $107M | $104M | $99M | $87M | $87M | $73M | $75M | $58M | $67M | $50M | · | $87M | $34M | $40M | · | $32M | |
| Accrued Liabilities | $301M | $313M | $334M | $326M | $282M | $238M | $261M | $255M | $216M | $210M | · | $222M | $90M | $84M | · | $88M | |
| Current Liabilities | $479M | $482M | $498M | $466M | $425M | $385M | $856M | $818M | $794M | $786M | · | $429M | $155M | $168M | · | $145M | |
| Capital Leases | $97M | $100M | $104M | $105M | $108M | $82M | $84M | $86M | $88M | $90M | · | $100M | · | · | · | · | |
| Deferred Tax | · | · | · | $23M | $24M | $47M | · | $7M | $27M | $40M | · | $132M | $5M | $1M | · | $2M | |
| Other Non-current Liabilities | $19M | $21M | $21M | $25M | $22M | $25M | $22M | $23M | $25M | $24M | · | $22M | $14M | $13M | · | $13M | |
| Total Liabilities | $720M | $707M | $730M | $697M | $665M | $623M | $1.07B | $1.02B | $1.02B | $1.02B | · | $1.17B | $227M | $235M | · | $212M | |
| Paid-in Capital | $3.23B | $3.21B | $3.17B | $3.10B | $3.07B | $3.05B | $3.03B | $2.95B | $2.91B | $2.89B | · | $2.86B | $657M | $645M | · | $606M | |
| Retained Earnings | $1.53B | $1.51B | $1.39B | $1.29B | $1.21B | $1.04B | $1.15B | $1.13B | $1.07B | $1.05B | · | $1.35B | $1.35B | $1.29B | · | $1.19B | |
| AOCI | $11M | $14M | $15M | $11M | $10M | $-2M | $-7M | $-7M | $-12M | $-11M | · | $-19M | $-19M | $-19M | · | $-32M | |
| Stockholders' Equity | $4.77B | $4.73B | $4.57B | $4.40B | $4.30B | $4.09B | $4.18B | $4.07B | $3.98B | $3.92B | $4.00B | $4.19B | $1.99B | $1.91B | $1.85B | $1.76B | |
| Liabilities + Equity | $5.49B | $5.44B | $5.30B | $5.10B | $4.96B | $4.71B | $5.25B | $5.09B | $4.99B | $4.94B | · | $5.36B | $2.21B | $2.15B | · | $1.98B |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $69M | $70M | $69M | $71M | $71M | $66M | $68M | $67M | $64M | $55M | $72M | $37M | $18M | $18M | $17M | $18M | |
| Stock-based Comp | $13M | $13M | $11M | $12M | $14M | $13M | $12M | $12M | $13M | $17M | $12M | $23M | $9M | $9M | $9M | $8M | |
| Amort. of Intangibles | $30M | $30M | $29M | $30M | $30M | $29M | $30M | $30M | $30M | $30M | $28M | $14M | $5M | $5M | $5M | $4M | |
| Restructuring | · | · | · | · | · | $154.0K | · | $6M | $-488.0K | $24M | · | · | · | · | · | · | |
| Other Non-cash | · | $-4M | · | · | · | $23M | · | · | · | $-13M | · | · | · | $-23M | · | · | |
| Operating Cash Flow | $210M | $202M | $249M | $250M | $78M | $177M | $210M | $204M | $54M | $52M | $105M | $50M | $35M | $53M | $64M | $33M | |
| CapEx | $33M | $40M | $46M | $36M | $47M | $36M | $17M | $42M | $28M | $29M | $23M | $22M | $18M | $16M | $18M | $12M | |
| Investing Cash Flow | $-129M | $-183M | $-111M | $-76M | $-299M | $131M | $-104M | $-15M | $-10M | $-47M | $321M | $-81M | $52M | $11M | $-60M | $-63M | |
| Stock Repurchased | $136M | $0 | $45M | $40M | $25M | $190M | $1M | $0 | $1M | $83M | · | · | · | · | $0 | $0 | |
| Net Stock Activity | · | $0 | · | · | · | $-190M | · | · | · | $-83M | · | · | · | · | · | · | |
| Financing Cash Flow | $-134M | $18M | $13M | $-32M | $-25M | $-635M | $60M | $20M | $9M | $-116M | $-237M | $1M | $1M | $3M | $14M | $13M | |
| Net Change in Cash | $-53M | $35M | $154M | $142M | $-232M | $-323M | $162M | $212M | $56M | $-113M | $188M | $-27M | $89M | $67M | $16M | $-17M | |
| Taxes Paid | $25M | $6M | $4M | $2M | $86M | $7M | $41M | $46M | $70M | $2M | $35M | $26M | $37M | $2M | $20M | $22M | |
| Free Cash Flow | · | $163M | · | · | · | $141M | · | · | · | $24M | · | · | · | $37M | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | · | 58.7% | 60.2% | · | 64.7% | 73.8% | 74.4% | · | 74.2% | |
| Operating Margin | 23.1% | 19.8% | · | 17.9% | 10.2% | 16.2% | · | 7.7% | 7.9% | 1.3% | · | 0.11% | 22.7% | 20.4% | · | 23.5% | |
| Net Margin | 19.2% | 16.4% | · | 15.5% | 27.2% | 12.6% | · | 8.3% | 5.0% | -1.2% | · | 0.26% | 19.8% | 17.8% | · | 18.7% | |
| Pretax Margin | 24.0% | 20.7% | · | 18.7% | 25.2% | 17.3% | · | 9.1% | 7.6% | -1.4% | · | 0.66% | 25.6% | 22.8% | · | 24.2% | |
| EBITDA Margin | 23.1% | 29.0% | · | 17.9% | 10.2% | 27.3% | · | 7.7% | 7.9% | 10.4% | · | 0.11% | 22.7% | 26.9% | · | 23.5% | |
| ROA | 2.9% | 2.5% | · | 2.3% | 4.1% | 1.6% | · | 0.99% | 0.88% | -0.20% | · | 0.03% | 2.8% | 2.4% | · | 2.4% | |
| ROE | 3.3% | 2.8% | · | 2.8% | 4.9% | 1.9% | · | 1.3% | 1.1% | -0.24% | · | 0.03% | 3.1% | 2.7% | · | 2.7% | |
| ROIC | 3.0% | 2.5% | · | 2.6% | 1.9% | 1.7% | · | 1.1% | 0.83% | 0.17% | · | 0.00% | 2.6% | 2.3% | · | 2.6% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.6 | 4.6 | · | 4.1 | 4.1 | 4.4 | · | 2.5 | 2.4 | 2.3 | · | 4.5 | 7.8 | 6.4 | · | 6.3 | |
| Quick Ratio | 2.7 | 2.7 | · | 1.4 | 1.4 | 1.4 | · | 0.8 | 0.9 | 0.8 | · | 1.6 | 3.5 | 3.0 | · | 3.3 |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.1 | · | 0.2 | 0.1 | 0.1 | · | 0.1 | 0.2 | 0.2 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.5 | 0.4 | · | 0.2 | 0.3 | 0.2 | · | 0.3 | |
| Receivables Turnover | 1.2 | 1.2 | · | 1.3 | 1.2 | 1.1 | · | 1.2 | 1.5 | 1.6 | · | 1.1 | 1.3 | 1.4 | · | 1.4 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue / Share | $5.75 | $5.50 | · | $5.68 | $5.46 | $4.28 | · | $4.53 | $4.60 | $4.48 | · | $3.33 | $2.87 | $2.71 | · | $2.51 | |
| Cash Flow / Share | · | $1.46 | · | · | · | $1.27 | · | · | · | $0.39 | · | · | · | $0.52 | · | · | |
| EPS (TTM) | $3.89 | $4.28 | · | $3.10 | $2.60 | $1.34 | · | $0.57 | $0.20 | $0.54 | · | $1.54 | $2.00 | $1.96 | · | $1.52 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $3.14B | $3.10B | · | $2.77B | $2.63B | $2.51B | · | $2.48B | $2.24B | $1.90B | · | $1.23B | $1.10B | $1.07B | · | $998M | |
| Net Income TTM | $535M | $587M | · | $424M | $357M | $186M | · | $92M | $41M | $67M | · | $158M | $204M | $201M | · | $155M | |
| P/E | 20.3 | 20.1 | · | 18.5 | 22.7 | 54.6 | · | 125.5 | 342.4 | 99.3 | · | 32.2 | 29.8 | 28.9 | · | 39.2 | |
| Earnings Yield | 4.9% | 5.0% | · | 5.4% | 4.4% | 1.8% | · | 0.80% | 0.29% | 1.0% | · | 3.1% | 3.4% | 3.5% | · | 2.5% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $2.94B | $2.52B | $1.57B | $1.02B | $958M |
| Gross Margin % | · | · | 65.0% | · | 75.0% |
| Operating Margin % | 16.3% | 6.6% | 8.5% | · | 17.9% |
| Net Income | $538M | $103M | $123M | $190M | $149M |
| Diluted EPS | $3.92 | $0.75 | $1.07 | $1.85 | $1.44 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 4.3 | 2.5 | 4.9 | · | 6.2 |
| Quick Ratio | 2.5 | 0.8 | 1.4 | · | 3.0 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $589M | $405M | $165M | · | $219M |
Institutional owners (13F) 639 filers · $10.4B total · As of Sept. 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
639
Value held
$10.4B
New positions
76
Exited positions
82
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 76 (-42 vs prior Q) | 82 (+32 vs prior Q) | 254 (+26 vs prior Q) | 180 (0 vs prior Q) | +5.4M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| VANGUARD GROUP INC | $921,072,916 | 10,549,455 | 8.82% | Shares |
| BlackRock, Inc. | $853,839,261 | 10,806,724 | 8.18% | Shares |
| JANUS HENDERSON GROUP PLC | $656,831,032 | 7,623,095 | 6.29% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $403,546,103 | 5,107,532 | 3.86% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $394,606,359 | 4,994,385 | 3.78% | Shares |
| Invesco Ltd. | $340,515,006 | 4,309,771 | 3.26% | Shares |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | $338,141,467 | 4,279,730 | 3.24% | Shares |
| STATE STREET CORP | $293,540,630 | 3,714,029 | 2.81% | Shares |
| Sculptor Capital LP | $237,030,000 | 3,000,000 | 2.27% | Shares |
| JPMORGAN CHASE & CO | $230,761,440 | 2,743,850 | 2.21% | Shares |
| Burgundy Asset Management Ltd. | $212,054,428 | 3,460,983 | 2.03% | Shares |
| ALLIANCEBERNSTEIN L.P. | $205,090,439 | 2,380,344 | 1.96% | Shares |
| BANK OF MONTREAL /CAN/ | $191,638,042 | 2,425,491 | 1.83% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $187,250,224 | 2,369,310 | 1.79% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $170,151,584 | 2,153,014 | 1.63% | Shares |
| GOLDMAN SACHS GROUP INC | $140,764,853 | 1,781,608 | 1.35% | Shares |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $135,630,225 | 1,716,621 | 1.30% | Shares |
| Boston Trust Walden Corp | $124,311,253 | 1,573,361 | 1.19% | Shares |
| Boston Partners | $122,847,510 | 1,554,990 | 1.18% | Shares |
| Allspring Global Investments Holdings, LLC | $119,384,889 | 1,571,681 | 1.14% | Shares |
| GENEVA CAPITAL MANAGEMENT LLC | $111,962,440 | 1,417,067 | 1.07% | Shares |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | $101,519,633 | 1,284,896 | 0.97% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $98,471,901 | 1,246,322 | 0.94% | Shares |
| Quantinno Capital Management LP | $96,320,933 | 1,219,098 | 0.92% | Shares |
| NORGES BANK | $89,048,300 | 1,127,051 | 0.85% | Shares |
| FULLER & THALER ASSET MANAGEMENT, INC. | $88,055,393 | 1,114,484 | 0.84% | Shares |
| MORGAN STANLEY | $86,496,544 | 1,094,753 | 0.83% | Shares |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $84,736,329 | 1,072,476 | 0.81% | Shares |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $81,207,111 | 1,027,808 | 0.78% | Shares |
| WELLS FARGO & COMPANY/MN | $78,742,680 | 996,617 | 0.75% | Shares |
| Madison Avenue Partners, LP | $73,891,416 | 935,216 | 0.71% | Shares |
| ANTIPODES PARTNERS Ltd | $71,581,796 | 905,984 | 0.69% | Shares |
| PARADIGM CAPITAL MANAGEMENT INC/NY | $70,042,286 | 886,499 | 0.67% | Shares |
| NORTHERN TRUST CORP | $69,578,813 | 880,633 | 0.67% | Shares |
| AXA Investment Managers S.A. | $68,885,959 | 1,202,828 | 0.66% | Shares |
| Global Alpha Capital Management Ltd. | $67,681,230 | 856,616 | 0.65% | Shares |
| Vestal Point Capital, LP | $67,158,500 | 850,000 | 0.64% | Shares |
| UBS Group AG | $65,909,432 | 834,191 | 0.63% | Shares |
| Bank of New York Mellon Corp | $61,258,598 | 775,328 | 0.59% | Shares |
| FMR LLC | $60,683,705 | 768,051 | 0.58% | Shares |
| BANK OF AMERICA CORP /DE/ | $58,239,298 | 737,113 | 0.56% | Shares |
| Stephens Investment Management Group LLC | $57,159,864 | 723,451 | 0.55% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $56,575,822 | 716,059 | 0.54% | Shares |
| RAYMOND JAMES FINANCIAL INC | $54,970,813 | 695,745 | 0.53% | Shares |
| Clark Capital Management Group, Inc. | $54,271,890 | 686,899 | 0.52% | Shares |
| AMERICAN CAPITAL MANAGEMENT INC | $51,599,219 | 653,072 | 0.49% | Shares |
| ANCHOR CAPITAL ADVISORS LLC | $51,225,201 | 648,338 | 0.49% | Shares |
| Camber Capital Management LP | $47,216,000 | 800,000 | 0.45% | Shares |
| Capital World Investors | $46,664,254 | 590,612 | 0.45% | Shares |
| Artemis Investment Management LLP | $45,305,914 | 573,420 | 0.43% | Shares |
Company insiders 22 insiders · 11 officers · 15 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Keith W Pfeil | President, CEO | Jan. 21, 2026 A | 0 | 0 | 0 | $0 |
| Daniel T Scavilla | President, CEO | Jan. 23, 2025 A | 0 | 0 | 0 | $0 |
| David M Demski | President, CEO | Jan. 27, 2022 A | 0 | 0 | 0 | $0 |
| Kyle Kline | Senior Vice President, CFO | Jan. 21, 2026 A | 0 | 0 | 2 | $-2,032,133 |
| Richard A Baron | Senior VP and CFO | May 2, 2014 M | 0 | 0 | 0 | $0 |
| Anthony L Williams | President | March 7, 2019 M | 0 | 0 | 0 | $0 |
| Kelly Huller | EVP, GC, Corporate Secretary | Feb. 25, 2026 M | 0 | 0 | 3 | $-3,441,700 |
| David C Paul | Executive Chairman | Jan. 21, 2026 A | 60,417 | 0 | 0 | $0 |
| Steven Payne | Chief Accounting Officer | Feb. 1, 2019 A | 0 | 0 | 0 | $0 |
| Eric Schwartz | Senior VP and General Counsel | June 25, 2018 M | 0 | 0 | 0 | $0 |
| Brett A Murphy | EVP, International Sales | Feb. 2, 2018 A | 35,217 | 0 | 0 | $0 |
| James R Tobin | Director | Sept. 15, 2026 M | 0 | 0 | 1 | $-2,237,400 |
| Stephen T Zarrilli | Director | Aug. 18, 2026 M | 0 | 0 | 2 | $-4,283,250 |
| David D Davidar | Director | July 27, 2026 G | 507,675 | 0 | 2 | $-4,169,000 |
| Ann D Rhoads | Director | June 4, 2026 M | 40,384 | 0 | 2 | $-818,000 |
| Dan Wolterman | Director | Jan. 21, 2026 A | 24,025 | 0 | 0 | $0 |
| Leslie V Norwalk | Director | Jan. 21, 2026 A | 10,419 | 0 | 2 | $-557,600 |
| Dan Lemaitre | Director | Jan. 21, 2026 A | 0 | 0 | 0 | $0 |
| John A Deford | Director | Jan. 21, 2026 A | 15,578 | 0 | 0 | $0 |
| Robert Andrew Douglas | Director | Jan. 21, 2026 A | 2,005 | 0 | 0 | $0 |
| Kurt Wheeler | Director | Jan. 22, 2019 A | 44,319 | 0 | 0 | $0 |
| Robert Liptak | Director | Jan. 22, 2019 A | 26,159 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 69 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| KMID · Virtus ETF Trust II | 2.90% | 16,797 NS | July 31, 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 2.26% | 300,351 NS | July 31, 2026 | N-PORT |
| GRPM · Invesco Exchange-Traded Fund Trust | 1.83% | 122,008 SH | Oct. 2, 2026 | Daily |
| HTEC · EXCHANGE TRADED CONCEPTS TRUST | 1.52% | 13,339 NS | July 31, 2026 | N-PORT |
| BUL · Pacer Funds Trust | 1.37% | 22,796 NS | July 31, 2026 | N-PORT |
| ROBO · EXCHANGE TRADED CONCEPTS TRUST | 1.35% | 340,460 NS | July 31, 2026 | N-PORT |
| IHI · iShares Trust | 1.25% | 541,723 SH | Sept. 11, 2026 | Daily |
| RFG · Invesco Exchange-Traded Fund Trust | 0.81% | 36,501 SH | Oct. 2, 2026 | Daily |
| MCOW · Pacer Funds Trust | 0.68% | 92 NS | July 31, 2026 | N-PORT |
| SMDX · Tidal Trust III | 0.58% | 9,542 NS | July 31, 2026 | N-PORT |
| CZA · Invesco Exchange-Traded Fund Trust | 0.50% | 13,493 SH | Oct. 2, 2026 | Daily |
| IVOG · VANGUARD ADMIRAL FUNDS | 0.47% | 111,810 SH | Aug. 19, 2026 | Daily |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0.34% | 20,104 NS | July 31, 2026 | N-PORT |
| FNY · First Trust Exchange-Traded AlphaDE… | 0.32% | 23,234 NS | July 31, 2026 | N-PORT |
| QVMM · Invesco Exchange-Traded Fund Trust … | 0.30% | 16,476 SH | Oct. 2, 2026 | Daily |
| JPUS · J.P. Morgan Exchange-Traded Fund Tr… | 0.29% | 16,839 NS | July 31, 2026 | N-PORT |
| ISCG · iShares Trust | 0.28% | 35,968 SH | Sept. 11, 2026 | Daily |
| BKMC · BNY Mellon ETF Trust | 0.27% | 22,533 NS | July 31, 2026 | N-PORT |
| PTMC · Pacer Funds Trust | 0.25% | 12,456 NS | July 31, 2026 | N-PORT |
| IVOO · VANGUARD ADMIRAL FUNDS | 0.25% | 183,180 SH | Aug. 19, 2026 | Daily |
| VBK · VANGUARD INDEX FUNDS | 0.24% | 1,499,816 SH | Aug. 19, 2026 | Daily |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0.19% | 49,674 NS | July 31, 2026 | N-PORT |
| MIDU · Direxion Shares ETF Trust | 0.19% | 1,664 NS | July 31, 2026 | N-PORT |
| FSMD · FIDELITY COVINGTON TRUST | 0.18% | 57,770 NS | July 31, 2026 | N-PORT |
| DFAT · Dimensional ETF Trust | 0.15% | 284,148 NS | July 31, 2026 | N-PORT |
| IYH · iShares Trust | 0.13% | 65,761 SH | Sept. 11, 2026 | Daily |
| VHT · VANGUARD WORLD FUND | 0.13% | 338,547 SH | Aug. 19, 2026 | Daily |
| RWK · Invesco Exchange-Traded Fund Trust … | 0.13% | 22,085 SH | Oct. 2, 2026 | Daily |
| FHLC · FIDELITY COVINGTON TRUST | 0.13% | 53,700 NS | July 31, 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0.13% | 245,718 NS | July 31, 2026 | N-PORT |
| FTLS · First Trust Exchange-Traded Fund III | 0.12% | 39,173 NS | July 31, 2026 | N-PORT |
| SMMD · iShares Trust | 0.11% | 59,918 SH | Sept. 11, 2026 | Daily |
| VB · VANGUARD INDEX FUNDS | 0.11% | 2,596,850 SH | Aug. 19, 2026 | Daily |
| VXF · VANGUARD INDEX FUNDS | 0.10% | 1,300,059 SH | Aug. 19, 2026 | Daily |
| VFMF · VANGUARD WELLINGTON FUND | 0.10% | 8,946 SH | Aug. 19, 2026 | Daily |
| DFSV · Dimensional ETF Trust | 0.10% | 103,731 NS | July 31, 2026 | N-PORT |
| INFO · Harbor ETF Trust | 0.10% | 10,513 NS | July 31, 2026 | N-PORT |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0.10% | 10,277 SH | Oct. 2, 2026 | Daily |
| FAD · First Trust Exchange-Traded AlphaDE… | 0.10% | 6,977 NS | July 31, 2026 | N-PORT |
| IWS · iShares Trust | 0.08% | 166,482 SH | Sept. 11, 2026 | Daily |
| WSML · iShares Trust | 0.08% | 6,832 SH | Sept. 11, 2026 | Daily |
| FNX · First Trust Exchange-Traded AlphaDE… | 0.07% | 13,036 NS | July 31, 2026 | N-PORT |
| IWR · iShares Trust | 0.06% | 458,676 SH | Sept. 11, 2026 | Daily |
| DFUV · Dimensional ETF Trust | 0.04% | 87,854 NS | July 31, 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.04% | 2,717 NS | July 31, 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.03% | 205,429 NS | July 31, 2026 | N-PORT |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0.03% | 20,026 SH | Oct. 2, 2026 | Daily |
| DFSU · Dimensional ETF Trust | 0.03% | 8,925 NS | July 31, 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.03% | 11,916 NS | July 31, 2026 | N-PORT |
| IUSG · iShares Trust | 0.02% | 99,439 SH | Sept. 11, 2026 | Daily |
| IWD · iShares Trust | 0.02% | 248,750 SH | Sept. 11, 2026 | Daily |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0.02% | 67,710 SH | Aug. 19, 2026 | Daily |
| ESGV · VANGUARD WORLD FUND | 0.02% | 25,284 SH | Aug. 19, 2026 | Daily |
| DFAU · Dimensional ETF Trust | 0.02% | 27,167 NS | July 31, 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0.01% | 38,185 NS | July 31, 2026 | N-PORT |
| TILT · FlexShares Trust | 0.01% | 3,476 NS | July 31, 2026 | N-PORT |
| IYY · iShares Trust | 0.01% | 4,949 SH | Sept. 11, 2026 | Daily |
| IWB · iShares Trust | 0.01% | 77,825 SH | Sept. 11, 2026 | Daily |
| PRF · Invesco Exchange-Traded Fund Trust | 0.01% | 15,270 SH | Oct. 2, 2026 | Daily |
| ITOT · iShares Trust | 0.01% | 145,193 SH | Sept. 11, 2026 | Daily |
| IWV · iShares Trust | 0.01% | 30,738 SH | Sept. 11, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | 0.01% | 3,596,212 SH | Aug. 19, 2026 | Daily |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0.01% | 89,702 SH | Aug. 19, 2026 | Daily |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0.01% | 18,804 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.01% | 9,508 SH | Aug. 19, 2026 | Daily |
| IJH · iShares Trust | · | 3,976,473 SH | Sept. 11, 2026 | Daily |
| IJK · iShares Trust | · | 657,157 SH | Sept. 11, 2026 | Daily |
| XJH · iShares Trust | · | 15,479 SH | Sept. 8, 2026 | Daily |
| ISCB · iShares Trust | · | 5,094 SH | Sept. 11, 2026 | Daily |
GMED Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 23 analysts
BUY
Median target
$100.00
+32.3%
4 17.4%
Strong Buy
12 52.2%
Buy
7 30.4%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
13 analysts · 2026-10-03Mean target $100.92 +33.5%
← Below all targets
Current price $75.60
Low$84.00
Mean$100.92
High$125.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| GMED | · | 22.3 | 16.7% | 18.3% | 12.1% | · |
| GEHC | · | 18.0 | 4.8% | 10.1% | 22.1% | 40.0% |
| ZBH | $28.66B | 25.3 | 7.2% | 8.6% | 5.6% | · |
| PEN | $12.20B | 68.8 | 17.5% | 12.7% | 13.1% | 67.1% |
| BAX | $13.05B | -10.2 | 5.7% | -8.5% | -14.6% | 30.0% |
| GKOS | $6.49B | -34.4 | 32.3% | -37.0% | -26.4% | 55.7% |
| PODD | $20.01B | 81.7 | 30.7% | 9.1% | 16.6% | 71.6% |
| TFX | · | -6.0 | 17.2% | -45.5% | -24.6% | 56.2% |
| ITGR | $2.69B | 27.1 | 8.0% | 5.5% | 6.0% | 27.0% |
| NVST | $3.56B | 77.5 | 8.3% | 1.7% | 1.5% | 54.7% |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | · |
Trading Signals Recent buy/sell signals with entry price and risk/reward ratio
BLUECHIP_DIP
Stopped out
risk 1
reward 1.71
entry
$80.54
R:R 1.71
BLUECHIP_DIP
Stopped out
risk 1
reward 1.92
entry
$79.89
R:R 1.92
BLUECHIP_DIP
Stopped out
risk 1
reward 1.79
entry
$82.29
R:R 1.79
No open signal right now — no card is filled, and that's honest.
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 6, 2026